UK MHRA Approves Antibody Cocktail for Covid-19 by AstraZeneca

The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’ has now licensed the […]

Continue Reading

United Kingdom Marks First Anniversary of Deployment of Oxford-AstraZeneca Covid-19 Vaccine

On 4th January 2021, the United Kingdom became the first country in the world for administering the novel corona virus vaccine developed by the Oxford University and AstraZeneca, and since then, around 50 million corona virus vaccines developed by the company ‘AstraZeneca’ have been administered in the United Kingdom, responsible for saving countless lives, along […]

Continue Reading